Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT01210859

Effects of Antimuscarinic Drugs on Overactive Bladder (OAB) Symptoms After Insertion of Ureteral Stents

Effects of Antimuscarinic Drugs on OAB Symptoms After Insertion of Ureteral Stents

Status
Withdrawn
Phase
Study type
Observational
Enrollment
0 (actual)
Sponsor
Meir Medical Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to check whether antimuscarinics that usually broadly used in the treatment of overactive bladder symptoms are effective in the treatment of those symptoms after insertion of ureteral stents. In order to study the efficacy of the treatment of OAB symptoms in stented patients the investigator will use a suitable questionnary.

Conditions

Timeline

Start date
2010-09-01
Primary completion
2011-12-01
Completion
2012-12-01
First posted
2010-09-29
Last updated
2013-09-26

Source: ClinicalTrials.gov record NCT01210859. Inclusion in this directory is not an endorsement.

Effects of Antimuscarinic Drugs on Overactive Bladder (OAB) Symptoms After Insertion of Ureteral Stents (NCT01210859) · Clinical Trials Directory